, , , , ,

This morning my husband and I were watching the news before leaving for work and I commented on the story that another terrorist attack against the U.S. is expected within the next six months. I told my husband that was fine timing for us to be planning to be in New York or Las Vegas, both of which are on our calendar and probably on most terrorists wish lists as well. My husband pointed out that Dub and his wife Laura live just a couple of miles from us, which probably puts us on the terrorist map as well.

Here in Texas, we tend to refer to George W. or “Dub” as “43” to distinguish him from his father, who was the 41st President of the United States. (Once when we were in London, there were six-inch headlines in the paper that said “Dub Comes to Town”, when the then-Present George W. Bush was making a state visit.)

But I digress.

The fact is, life today is a constant risk-benefit analysis. I probably am exposed to more risk driving in rush-hour traffic twice a day with crazy Texans than I am having a terrorist blow up my neighborhood. (My nephew, who escaped from the Word Trade Center on 9/11 might disagree.) But I get a lot of benefit from showing up for work every morning, so I accept that risk.

Today is Enbrel day. As I look back to a year and a half ago when I was first diagnosed, and I avidly read all the literature my rheumatologist provided, including all the side effects of the drugs, I was overwhelmed. I’ve never been one for long-term drug therapy if it can be avoided because even small side-effects can escalate if given enough time.  I went off drug therapy after I had my hip replaced and less than six months later got to replace my shoulder. 

Yes. I worry about the risks of the strong, constant barrage of drugs that I flood my system with to keep the disease at bay. But I reap the benefit of having a happy, busy, productive life — at least for a while longer.  There is no cure, but there are benefits to be had.

I hope your day is filled with benefits of all kinds. Thanks for checking in.